Minnesota has a large contingency of medical device companies. In general, medical device companies say the approval process is slow while FDA critics say the agency’s review have not been stringent enough.
“The intent here is about reducing the time and cost to develop, assess and review medical devices, so we can bring important technology to patients more quickly but with robust data to know that in fact they are going to benefit patients,” Jeffery Shuren, MD, who oversees the FDA division responsible for medical devices, said.
Related Articles on Medical Devices:
CMS Targets Unnecessary Medical Technology, Devices
Global Medical Device Market Will Reach $350B by 2016
Qualcomm Launches Medical Devices Subsidiary Backed by $100M Fund
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.